Differential binding characteristics of agonists at 5-HT3 receptor recognition sites in NG108-15 neuroblastoma-glioma cells labelled by and [3H]granisetron
- 25 April 1993
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 45 (10) , 2155-2158
- https://doi.org/10.1016/0006-2952(93)90030-z
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Agonist interactions with 5‐HT3 receptor recognition sites in the rat entorhinal cortex labelled by structurally diverse radioligandsBritish Journal of Pharmacology, 1992
- Involvement of tryptophan residue(s) in the specific binding of agonists/antagonists to 5-HT3 receptors in NG108-15 clonal cellsBiochemical Pharmacology, 1991
- Characterisation and autoradiographic localisation of 5-HT3 receptor recognition sites identified with [3H]-(S)-zacopride in the forebrain of the ratNeuropharmacology, 1990
- Common pharmacological and physico-chemical properties of 5-HT3 binding sites in the rat cerebral cortex and NG 108-15 clonal cellsBiochemical Pharmacology, 1990
- [3H]-BRL 43694 (granisetron), a specific ligand for 5-HT3 binding sites in rat brain cortical membranesBiochemical Pharmacology, 1989
- Electrophysiology of 5-HT3 receptors in neuronal cell linesTrends in Pharmacological Sciences, 1989
- Characterisation of 5-HT3 recognition sites in membranes of NG 108-15 neuroblastoma-glioma cells with [3H]ICS 205-930Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1988
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973